Close
Skip to content
  • About Us
  • Resources
  • Support
  • Join Us
  • Contact Us
Menu
  • About Us
  • Resources
  • Support
  • Join Us
  • Contact Us
MEMBER LOGIN
Search
Close

Julie Bergeron

Projects / Working Groups
  • AML in the Elderly Guidelines
  • APL Guidelines
  • Clinical Utility of Quantitative FLT-3 Assessment in AML Recommendations
Acute Leukemia Information
  • AMLHub
  • NCI (leukemia)
  • Leukemia and Lymphoma Society Canada
  • Canadian Cancer Society
Guidelines, Position Statements & Disease-Specific Protocols
  • CLSG/GCEL-specific
    • coming soon
  • Other Canadian
    • PM Febrile Neutropenia Algorithm
    • AML in Elderly
    • APL
  • Other
    • European Leukemia Net (ELN)
    • NCCN Guidelines
    • NCI Leukemia
Clinical Trials
  • CLSG/GCEL Trials
  • Canadian (CCTG, individual institutions, provincial)
    • Canadian Cancer Trials Group (CCTG)
    • Consortium de recherche en oncologie clinique du Québec
    • Princess Margaret Leukemia Program
    • Alberta
  • International
    • ClinicalTrials.Gov
Cancer Research
& Treatment Groups
  • American Association for Cancer Research (AACR)
  • Groupe d’étude en oncologie du Québec
Acute Leukemia Resources
  • Key Publications
    • WHO 2016 Myeloid Neoplasms and Acute Leukemia
    • ELN 2017 AML
  • Canadian Cancer Centres / Leukemia Programs
    • British Columbia
      • The Leukemia/Bone Marrow Transplant Program of British Columbia
    • Alberta
      • Albert Health Services
      • Tom Baker Cancer Centre
    • Saskatchewan
      • Saskatoon Cancer Centre
      • Saskatchewan Hematology Blog
    • Manitoba
      • CancerCare Manitoba – Health Sciences Centre Winnipeg
    • Ontario
      • Thunder Bay Regional Health Sciences Centre
      • Health Sciences North – Northeast Cancer Centre – Sudbury
      • Windsor Regional Hospital – Cancer Program
      • London Regional Cancer Program
      • Grand River Regional Cancer Centre – Grand River Hospital – Kitchener
      • Juravinski Cancer Centre – Juravinski Hospital – Hamilton
      • Princess Margaret Cancer Centre
        • UHN Leukemia Site Group
      • Sunnybrook Health Sciences Centre – Odette Cancer Centre
      • Kingston – Kingston Health Sciences
      • Ottawa – The Ottawa Hospital
        • The Ottawa Hospital Hematology
        • Blood and Marrow Transplant Program
    • Quebec
      • Montreal – MUHC
      • Montreal – Jewish General Hospital
      • Montreal – HMR/UoM
      • Sherbrooke
      • Quebec City
    • New Brunswick
      • coming soon
    • Nova Scotia
      • Nova Scotia Health
      • Dalhousie University – Division of Hematology
    • Newfoundland
      • Dr. H. Bliss Murphy Cancer Centre – St. John’s
  • Provinical Links
    • Canadian Association of Provincial Cancer Agencies
    • BC Cancer
    • CancerControl Alberta – Alberta Health Services
    • Saskatchewan Cancer Agency
    • CancerCare Manitoba
    • Cancer Care Ontario – Ontario Health
    • Programme Québécois de Cancérologie – Quebec Ministry of Health and Social Services
    • New Brunswick Cancer Network
    • Cancer Care Nova Scotia – Nova Scotia Health
    • Prince Edward Island Cancer Treatment Centre
    • Eastern Health Cancer Care, Newfoundland and Labrador
Professional Societies
& Associations
  • Canadian Hematology Society
  • American Society of Hematology (ASH)
  • European Hematology Association (EHA)
  • American Society of Clinical Oncology
Canadian New Drug Approval Process / Compassionate Drug Access
  • Health Canada
    • Notice of Compliance Searchable Database
    • Submissions currently under review: New drug submissions
    • Submissions currently under review: Supplemental new drug submissions for new uses
    • Submissions formerly under review: New drug submissions
    • Submissions formerly under review: Supplemental new drug submissions for new uses
  • INESSS
    • Institut national d’excellence en santé et en services sociaux (INESSS)
  • CADTH/pCODR
    • Canadian Agency for Drugs and Technologies in Health (CADTH)
    • pan-Canadian Oncology Drug Review (pCODR)

CANADIAN LEUKEMIA STUDY GROUP © 2021 All Rights Reserved.

Member Login

  • Acute Leukemia Information
  • AMLHub
  • NCI (leukemia)
  • Leukemia and Lymphoma Society Canada
  • Canadian Cancer Society
  • Guidelines, Position Statements
    & Disease-Specific Protocols
  • CLSG/GCEL-specific
    • coming soon
  • Other Canadian
    • PM Febrile Neutropenia Algorithm
    • AML in Elderly
    • APL
  • Other
    • European Leukemia Net (ELN)
    • NCCN Guidelines
    • NCI Leukemia
  • Clinical Trials
  • CLSG/GCEL Trials
  • Canadian (CCTG, individual institutions, provincial)
    • Canadian Cancer Trials Group (CCTG)
    • Consortium de recherche en oncologie clinique du Québec
    • Princess Margaret Leukemia Program
    • Alberta
  • International
    • ClinicalTrials.Gov
  • Cancer Research
    & Treatment Groups
  • American Association for Cancer Research (AACR)
  • Groupe d’étude en oncologie du Québec
  • Acute Leukemia Resources
  • Key Publications
    • WHO 2016 Myeloid Neoplasms and Acute Leukemia
    • ELN 2017 AML
  • Canadian Cancer Centres / Leukemia Programs
    • British Columbia
      • The Leukemia/Bone Marrow Transplant Program of British Columbia
    • Alberta
      • Albert Health Services
      • Tom Baker Cancer Centre
    • Saskatchewan
      • Saskatoon Cancer Centre
      • Saskatchewan Hematology Blog
    • Manitoba
      • CancerCare Manitoba – Health Sciences Centre Winnipeg
    • Ontario
      • Thunder Bay Regional Health Sciences Centre
      • Health Sciences North – Northeast Cancer Centre – Sudbury
      • Windsor Regional Hospital – Cancer Program
      • London Regional Cancer Program
      • Grand River Regional Cancer Centre – Grand River Hospital – Kitchener
      • Juravinski Cancer Centre – Juravinski Hospital – Hamilton
      • Princess Margaret Cancer Centre
        • UHN Leukemia Site Group
      • Sunnybrook Health Sciences Centre – Odette Cancer Centre
      • Kingston – Kingston Health Sciences
      • Ottawa – The Ottawa Hospital
        • The Ottawa Hospital Hematology
        • Blood and Marrow Transplant Program
    • Quebec
      • Montreal – MUHC
      • Montreal – Jewish General Hospital
      • Montreal – HMR/UoM
      • Sherbrooke
      • Quebec City
    • New Brunswick
      • coming soon
    • Nova Scotia
      • Nova Scotia Health
      • Dalhousie University – Division of Hematology
    • Newfoundland
      • Dr. H. Bliss Murphy Cancer Centre – St. John’s
  • Provinical Links
    • Canadian Association of Provincial Cancer Agencies
    • BC Cancer
    • CancerControl Alberta – Alberta Health Services
    • Saskatchewan Cancer Agency
    • CancerCare Manitoba
    • Cancer Care Ontario – Ontario Health
    • Programme Québécois de Cancérologie – Quebec Ministry of Health and Social Services
    • New Brunswick Cancer Network
    • Cancer Care Nova Scotia – Nova Scotia Health
    • Prince Edward Island Cancer Treatment Centre
    • Eastern Health Cancer Care, Newfoundland and Labrador
  • Professional Societies
    & Associations
  • Canadian Hematology Society
  • American Society of Hematology (ASH)
  • European Hematology Association (EHA)
  • American Society of Clinical Oncology
  • Canadian New Drug
    Approval Process
  • Health Canada
    • Notice of Compliance Searchable Database
    • Submissions currently under review: New drug submissions
    • Submissions currently under review: Supplemental new drug submissions for new uses
    • Submissions formerly under review: New drug submissions
    • Submissions formerly under review: Supplemental new drug submissions for new uses
  • INESSS
    • Institut national d’excellence en santé et en services sociaux (INESSS)
  • CADTH/pCODR
    • Canadian Agency for Drugs and Technologies in Health (CADTH)
    • pan-Canadian Oncology Drug Review (pCODR)
  • Compassionate Drug Access
  • AMLHub
  • NCI (leukemia)
  • Leukemia and Lymphoma Society Canada
  • Canadian Cancer Society